Applicant, as named in the Orange Book
Corcept Therap
Corcept Therapeutics Inc · Nasdaq: CORT
Company and ticker: cliffwatch mapping, checked against SEC EDGAR · SEC filings
Next listed expiry: Korlym on 22 Aug 2038. 2 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Korlym NDA 202107 mifepristone | 22 Aug 2038 patent, carve-out possible |
| Lifyorli (Copackaged) NDA 220641 relacorilant | 22 Dec 2041 patent |
Recent events
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.